Clinical updates, including trial initiations, enrollment status and data readouts and publications: Avelas, Menarini.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Angion, Arch, Avelas, Cellectar, Clene, Karuna, Keros, GT, Novartis, Oncopeptides, Regenxbio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Masimo, Natera.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Akebia, Amgen, Active, Aileron, Arcutis, Biohaven, Cymabay, Genmab, Immunic, Innovent, Janssen, Kadimastem, Lilly, Lipocine, Myokardia, Polyphor, Takeda.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, American Brivision, Arch, Astrazeneca, Biontech, Bridgebio, Chiasma, Cleave, Corcept, Cue, Grifols, Interion, Mind, Miragen, Orion, Pfizer, Plus, Reata, Recordati, Redhill, Spectrum.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Oncimmune.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Arcutis, Baudax, Endo, Highlight, Horizon, Ico, Pfizer.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abiomed, Veracyte.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Boehringer, Cynata, Eisai, Eli Lilly, Enterome, Genocea, Onconova, Redhill, Sab, Salarius, Sanofi, Terns, TFF, Theralase, Trillium, Tychan, Xeris.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Setpoint Medical, Visualdx.